Abstract
Background: Notch receptors are involved in kidney development and pathogenesis of inflammatory glomerular diseases. Given the secretion of Y-box (YB) protein-1 following cytokine stimulation and subsequent extracellular association with membrane receptor Notch-3 in vitro, we elucidated functional effects of YB-1 targeting on the Notch-3 signaling pathway. Methods: Rat mesangial cells were challenged with a monoclonal anti-YB-1 antibody (YB-1-mAb) and analyzed for YB-1 and Notch-3 expression. Notch-3 expression in mice with a targeted disruption of one YB-1 allele (YB-1+/d) was compared with their wild-type littermates. Furthermore, YB-1-mAb was applied during mesangioproliferative anti-Thy1.1 nephritis, and glomerular Notch-3, Notch target genes and YB-1 expression were analyzed by immunohistochemistry, quantitative real-time PCR and immunoblotting. Results: Upon challenge with YB-1-mAb, rat mesangial cells showed an increased expression of YB-1 and Notch-3 protein. Concordantly, we found a significant upregulation of Notch-3 expression in renal cells of YB-1+/d mice. YB-1-mAb treatment in anti-Thy1.1 nephritis resulted in enhanced mesangial Notch-3 expression and differential Notch target gene activation (HES2/Hey-2). Notably, YB-1 mRNA content did not differ between groups; however, glomerular YB-1 protein was significantly increased, suggesting a posttranslational mechanism. Conclusion: Extracellular targeting of YB-1 potently induces glomerular Notch-3 receptor expression, Notch signaling and YB-1 stabilization, most likely via an autoregulatory feedback mechanism.
Journal Section:
Original Paper
References
1.
Fortini ME: Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009;16:633–647.
[PubMed]
2.
De Strooper B, Annaert W, Cupers P, et al: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999;398:518–522.
[PubMed]
3.
Iso T, Hamamori Y, Kedes L: Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003;23:543–553.
[PubMed]
4.
Niranjan T, Bielesz B, Gruenwald A, et al: The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008;14:290–298.
[PubMed]
5.
Waters AM, Wu MY, Onay T, et al: Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008;19:1139–1157.
[PubMed]
6.
Cheng HT, Kopan R: The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int 2005;68:1951–1952.
[PubMed]
7.
Kobayashi T, Terada Y, Kuwana H, et al: Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008;73:1240–1250.
[PubMed]
8.
Rauen T, Raffetseder U, Frye BC, et al: YB-1 acts as ligand for Notch-3 receptors and modulates receptor activation. J Biol Chem 2009;284:26928–26940.
[PubMed]
9.
Mertens PR, Steinmann K, Alfonso-Jaume MA, et al: Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells. J Biol Chem 2002;277:24875–24882.
[PubMed]
10.
Raffetseder U, Rauen T, Djudjaj S, et al: Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. Kidney Int 2008;75:185–196.
[PubMed]
11.
Raffetseder U, Frye BC, Rauen T, et al: Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 2003;278:18241–18248.
[PubMed]
12.
Chen CY, Gherzi R, Andersen JS, et al: Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000;14:1236–1248.
[PubMed]
13.
Lu ZH, Books JT, Ley T: YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. MCB 2005;11:4625–4637.
14.
Frye BC, Halfter S, Djudjaj S, et al: Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen. EMBO Rep 2009;10:783–789.
[PubMed]
15.
Floege J, Ostendorf T, Janssen U, et al: Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 1999;154:169–179.
[PubMed]
16.
Dahl E, En-Nia A, Wiesmann F, et al: Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer 2009;9:410.
[PubMed]
17.
van Roeyen CR, Eitner F, Martinkus S, et al: Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 2005;16:2985–2996.
[PubMed]
18.
Capowski EE, Esnault S, Bhattacharya S, et al: Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 2001;167:5970–5976.
[PubMed]
19.
Joutel A, Andreux F, Gaulis S, et al: The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000;105:597–605.
[PubMed]
20.
Ostendorf T, Rong S, Boor P, et al: Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006;17:1054–1062.
[PubMed]
21.
Ostendorf T, van Roeyen CR, Peterson JD, et al: A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2003;14:2237–2247.
[PubMed]
22.
Cove-Smith A, Hendry BM: The regulation of mesangial cell proliferation. Nephron Exp Nephrol 2008;108:74–79.
[PubMed]
23.
Floege J, Eitner F, Alpers CE: A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008;19:12–23.
[PubMed]
24.
Nekrasov MP, Ivshina MP, Chernov KG, et al: The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage. J Biol Chem 2003;278:13936–13943.
[PubMed]
25.
Fukuda T, Ashizuka M, Nakamura T, et al: Characterization of the 5′-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein. Nucleic Acids Res 2004;32:611–622.
[PubMed]
26.
Schaefer L, Ren S, Schaefer RM, et al: Nephrin expression is increased in anti-Thy1.1-induced glomerulonephritis in rats. Biochem Biophys Res Commun 1999;324:247–254.
27.
Sweeney C, Morrow D, Birney YA, et al: Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J 2004;18:1421–1423.
[PubMed]
© 2011 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2011
You do not currently have access to this content.
